Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuromodulation and Dynamic Balance in Stroke

NCT: NCT05135533 · COMPLETED

NCT IDNCT05135533
StatusCOMPLETED
Start Date2023-08-28
Completion2025-07-24
SponsorMedical University of South Carolina (OTHER)
First posted
Last updated

Brief Summary

Portable Neuromodulation Stimulator (PoNS) is non-invasive stimulation device placed on the tongue to stimulate those brain regions understood to be important for maintaining balance. This research study aims to collect evidence that PoNS therapy along with balance training improves postural and walking stability post-stroke.

Frequently Asked Questions

What is Neuromodulation and Dynamic Balance in Stroke?

Neuromodulation and Dynamic Balance in Stroke is a clinical trial registered under NCT05135533. Current status: COMPLETED.

What is the status of NCT05135533?

The current status of NCT05135533 (Neuromodulation and Dynamic Balance in Stroke) is: COMPLETED.

When did Neuromodulation and Dynamic Balance in Stroke start?

Neuromodulation and Dynamic Balance in Stroke started on 2023-08-28.

Related Devices

K253061Portable Neuromodulation Stimulator (PoNS)Helius Medical, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑